Physician profile
Hilton Franqui-Rivera
NPI 1336342096
$131,389.47
in general payments reported to CMS, 2019-2025
14 companies · $39K in 2025
The $39K reported for 2025 was more than what 94% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $6,846 · 2021: $8,817 · 2022: $13K · 2023: $24K · 2024: $18K · 2025: $39K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $35K · Travel and Lodging: $21K · Consulting Fee: $15K · Food and Beverage: $9,886.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $35,325.00 |
| Travel and Lodging | $20,554.40 |
| Consulting Fee | $15,300.00 |
| Food and Beverage | $9,885.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $64,421.05 | 2019-2025 | Lifevest |
| Medtronic, INC. | $44,787.66 | 2019-2025 | Micra, Aurora Ev-Icd Mri Surescan, Na |
| Abbott Laboratories | $16,223.51 | 2019-2025 | Accent, Aveir, Gallant |
| Boston Scientific Corporation | $3,399.62 | 2019-2025 | Farapulse, Watchman Flx, General - Therapies |
| Medtronic Vascular, INC. | $718.61 | 2020 | |
| Amgen INC. | $585.33 | 2020-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $365.95 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $227.66 | 2020-2025 | Camzyos, Eliquis |
| Pbg Puerto Rico LLC | $195.57 | 2019-2025 | |
| Biotronik INC. | $191.43 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2025 | |
| Johnson and Johnson International | $112.97 | 2025 | Carto 3 |
| Novartis Pharmaceuticals Corporation | $20.00 | 2025 | |
| Chiesi USA, INC. | $15.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hilton Franqui-Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.